2024 Oral Proteins And Peptides Market Summary: 5 Key Findings
Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!
What Growth Projections are in Place for the Oral Proteins And Peptides Market Between 2024-2033?
The market for oral proteins and peptides has experienced a tremendous expansion in the past few years. Expected to rise from $1.04 billion in 2023 to $1.27 billion in 2024, it sees a compound annual growth rate (CAGR) of 22.1%. The historical growth is linked to several factors. These include growing incidences of chronic illnesses, increased funding in biotech for creating oral protein-based therapies, a consumer trend towards non-invasive procedures, expansion of the biopharmaceutical sector, and an enhanced emphasis on personalized medication.
The market for oral proteins and peptides is projected to witness stellar growth in the ensuing years, expanding to $2.86 billion in 2028 with a compound annual growth rate of 22.4%. Factors contributing to the growth during this forecasted period include an amplified emphasis on patient-centered medicines, an increase in the ageing population, elevated healthcare spending, an escalating need for cancer diagnostics, and a growing preference for orally-administered drugs. Key trends foreseen in this period encompass the formation of innovative oral peptides with improved stability and performance, incorporation of artificial intelligence in the drug formulation procedures for oral delivery, advanced medicinal treatments, progress in drug delivery technologies, and inventive formulations of oral insulin.
Claim Your Free Sample of the Global Oral Proteins And Peptides Market Report Today!
https://www.thebusinessresearchcompany.com/sample.aspx?id=19629&type=smp
What Are the Major Factors Contributing to the oral proteins and peptides Market Expansion?
The oral proteins and peptides market is poised to expand in the future fuelled by the booming biopharmaceutical industry. This industry is a subset of the wider pharmaceutical world that prioritizes biological sources for drug development, production, and commercialization. The growth factors of the biopharmaceutical industry are updated biotechnology, surging demand for custom medicines, the escalating occurrence of chronic illnesses, and heightened investment in research and development. The deployment of oral proteins and peptides in biopharmaceuticals could facilitate the non-invasive administration of therapeutics, augment patient acquiescence, and lessen the reliance on injections. They possess the potential to target specific ailments with enhanced stability and absorption in the digestive tract. As per the European Federation of Pharmaceutical Industries and Associations (EFPIA), a Belgium-based European trade consortium representing the pharmaceutical realm, in June 2023, the total biopharmaceutical production in Europe was reported to be at $384,200 million (€340,000 million) in 2022, marking a rise of roughly 4.95% from $366,267 million (€323,950 million) in 2021. Thus, growth in the oral proteins and peptides market is fuelled by the increasing biopharmaceutical industry.
Which Key Segments Shape the Oral Proteins And Peptides Market?
1) By Drug Type: Linaclotide, Calcitonin, Insulin, Plecanatide, Octreotide
2) By Biological Target: Guanylate Cyclase-C (GC-C1), Insulin Receptor, Oxalate, Other Biological Targets
3) By Mechanism Of Action: Receptor Stimulation, Substrate Degradation, Other Mechanisms Of Action
4) By Application: Gastrointestinal Disorders, Bone Disease, Neurological Disorders, Diabetes, Metabolic Disorders, Hormonal Disorder, Cancer
What Are the Transformative Trends Influencing the Oral Proteins And Peptides Market?
Major players in the oral proteins and peptides market, including Novo Nordisk India, are keen on launching innovative medications to increase patient comfort and compliance. For instance, Oral Semaglutide is a prime example of such advancements offering an impressive leap forward in the market. Oral Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, traditionally delivered via injection for treating type 2 diabetes and obesity, is now available in oral form. Significantly, in January 2022, Novo Nordisk India launched the world’s first oral semaglutide, a ground-breaking progress in the field of diabetes treatment. Semaglutide, a GLP-1 receptor analogue (GLP-1 RA) which was previously available only as an injectable, now comes in an easy-to-use oral format, designed to manage type 2 diabetes. The advent of this product marks a significant transformation of diabetes care as it paves the way for future advancements in oral insulin formulations, with the potential to deliver more efficient and user-friendly treatment options.
Order Now for Fast Delivery of Your Oral Proteins And Peptides Market Report!
https://www.thebusinessresearchcompany.com/report/oral-proteins-and-peptides-global-market-report
What Regions Are Leading the Growth Trajectory of the Oral Proteins And Peptides Market?
North America was the largest region in the oral proteins and peptides market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the oral proteins and peptides market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The Oral Proteins And Peptides Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the oral proteins and peptides market, its market share, and analyzes key competitors along with their market positions.
The Table Of Content For The Oral Proteins And Peptides Market Include
1. Oral Proteins And Peptides Market Executive Summary
2. Oral Proteins And Peptides Market Segments
3. Oral Proteins And Peptides Market Size And Template Market Growth Rate
4. Key Oral Proteins And Peptides Market Trends
5. Major Oral Proteins And Peptides Market Drivers
……
25. Key Mergers And Acquisitions In The Oral Proteins And Peptides Market
26. Top Oral Proteins And Peptides Companies
27. Oral Proteins And Peptides Market Opportunities And Strategies
28. Oral Proteins And Peptides Market, Conclusions And Recommendations
29. Appendix
Discover Related Reports by The Business Research Company:
Global Oral Biologics and Biosimilar Drugs Market Report and Industry Trends
Oral Contraceptive Pills Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/oral-contraceptive-pills-global-market-report
Oral Thin Films Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/oral-thin-films-global-market-report
Learn More About The Business Research Company
The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
